ACE2 and primary biliary cholangitis: The elevated levels of anti-pIgR autoantibodies, together with other antigen-specific autoantibodies, further damage DUOX2+ACE2+ small cholangiocytes in the small bile ducts, impairing bile secretion, and contribute to the development of PBC, even if patients fail to develop AMA-M2 antibodies.